Cabot Corporation Collaborates with IFF Health and Biosciences to Develop Sustainable Reinforcing Additives
Cabot Corporation (NYSE: CBT) has signed a Memorandum of Understanding (MOU) with IFF Health and Biosciences to develop and commercialize sustainable reinforcing additives for rubber products. This collaboration aims to reduce greenhouse gas emissions and increase renewable bio-based content in rubber applications. Utilizing IFF’s Nuvolve™ engineered polysaccharide, developed from European sugar beets, Cabot will lead the project, integrating it with its reinforcing carbons. This partnership aligns with Cabot's commitment to sustainability and innovation in the rubber industry.
- Collaboration with IFF focuses on sustainability and innovation in rubber additive development.
- Use of Nuvolve™ polysaccharide can enhance renewable content and reduce emissions.
- Cabot leading development positions it favorably within the sustainable materials market.
- None.
Collaboration Includes the Expansion of New Technologies for Advancing the Development and Commercialization of Sustainable Reinforcing Additives in Rubber Applications
Over the last year, the two companies have been exploring the development of novel, highly sustainable rubber reinforcing additives based on the use of IFF’s Nuvolve™ engineered polysaccharide. Created by enzymatic polymerization of sustainable European sugar beets, Nuvolve™ engineered polysaccharide will be used as a rubber reinforcing material to be blended with Cabot’s reinforcing carbons. Under the terms of this new MOU, Cabot will lead the development and commercialization of this novel product as a complementary material to Cabot’s reinforcing carbons in rubber applications, leveraging the sustainability benefits of a renewable resourced material without compromising performance and safety.
“As a leading producer of reinforcing carbons and performance rubber composites, enabling sustainability through innovation and collaboration is core to our work. We are committed to investing in technologies that advance the sustainability and performance of our products and their use,” said Dr.
“We are thrilled to bring our enzymatic polymerization technology to Cabot which will provide new performance opportunities with a sustainable benefit in key markets where rubber reinforcing additives are used,” said
“This MOU demonstrates our commitment to invest in opportunities that respond to our customer demands for increasingly sustainable products,” said
For more information about Cabot’s sustainability initiatives, visit cabotcorp.com/sustainability.
ABOUT
ABOUT IFF HEALTH & BIOSCIENCES
IFF’s Health & Biosciences (H&B) division is captivated by bioscience, fascinated by its potential, inspired by its vitality. We channel that passion into sustainable, life-enhancing technologies across a broad range of industries. By creatively applying our extensive expertise to customer and consumers’ needs, we harness the science that breathes life into us, and delivers safer, healthier and more sustainable solutions.
ABOUT IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and sensorial experiences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter, Facebook, Instagram, and LinkedIn.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in the press release regarding Cabot's business that are not historical facts are forward looking statements that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211201005670/en/
Corporate Communications
emily.moran@cabotcorp.com
(617) 460-4517
Investor Relations
steve.delahunt@cabotcorp.com
(617) 342-6255
Source:
FAQ
What is the purpose of the MOU between Cabot and IFF?
What technology will be used in the collaboration between Cabot and IFF?
How does the partnership impact Cabot's sustainability goals?
What are the potential applications for the new additives developed by Cabot and IFF?